New FDA rule for pharma advertisements requires side effects to be explained clearly
Ever notice how the narrator of a drug advertisement on TV can breeze through the side effects in a tone that’s easy to tune out? That’s changing with new rules from the FDA released Monday that establish more robust standards to ensure better clarity around a pharma’s major statement on the side effects and risks of a drug in direct-to-consumer (DTC) TV and radio ads.
This final rule comes in addition to longstanding requirements that companies include such risk information in prescription drug ads, but in this case, the FDA and Congress wanted to more effectively convey those risks.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.